Selling your patents is the fastest way to turn a $10M asset into a $1M cheque. Most founders do it anyway.
Here is the brutal truth: a patent sale is a one-time event. A patent licence is a revenue stream. Over a ten-year patent life, a well-structured licence generates between 3x and 10x more cash than the equivalent lump-sum sale.
At Beyond Elevation, we restructured Position Imaging's 66-patent portfolio into licensable units instead of letting them sell the IP wholesale. The delta between those two paths was eight figures.
This post answers the question every founder with real IP eventually faces: licence or sell?
Should you license your patents or sell them outright?
License by default. Sell only in three specific situations: you are out of cash in 90 days, the patent covers a non-core business line you will never return to, or you cannot afford to enforce the patent.
Everything else should be licensed. Here is why the math is one-sided.
A typical patent sale prices the asset at 1x to 3x of estimated annual royalty value. A licence captures 3% to 15% of the licensee's revenue every year for the remaining life of the patent — often 10 to 15 years.
Run the numbers on a patent generating $1M in annual royalties. Sell it for $3M once. Or licence it at $1M per year across 12 years for $12M. Selling costs you $9M and the optionality.
Why do most founders sell instead of license?
Founders sell because selling is easier. A sale closes in 90 days. A licence takes 4 to 12 months of negotiation, enforcement planning, and ongoing administration.
Cash pressure is the second reason. A bridge round is delayed, payroll is looming, and a patent buyer waves a cheque. Founders take it.
The third reason is ignorance. Most founders have never seen a licensing deal structured properly. They do not know that patent-backed lending, royalty advances, and structured licences unlock cash without giving the asset away forever.
Beyond Elevation exists because of this gap. Founders come to us with an asset sale on the table and leave with a licensing structure that keeps the IP and still solves the cash problem.
When does selling a patent actually make sense?
Selling a patent makes sense in exactly three scenarios. Any sale outside these three is usually a pricing mistake.
1. Non-core IP you will never commercialise. If you invented something in an adjacent field you have no plan to enter, a sale to a strategic buyer in that field is efficient. You capture value you would otherwise leave dormant.
2. Enforcement is impossible. If your portfolio is strong but you lack the capital or appetite to litigate infringement, selling to a well-funded acquirer who can enforce may beat holding a licence nobody pays.
3. Terminal cash crunch. If payroll will not clear in 30 days and no other capital source is available, sell the IP, survive, and rebuild. Survival beats optimisation.
That is the entire list. If you do not fit one of these three, license.
How do you structure a licensing deal that actually pays?
The deal structure determines whether a licence produces real revenue or becomes a piece of paper nobody enforces. Five components matter.
Upfront payment. Never sign a licence without a non-refundable upfront fee. This proves licensee commitment and front-loads your cash. Standard range: 10% to 30% of total expected contract value.
Running royalty. Tie it to licensee revenue, not net profit. Profit can be engineered down. Revenue cannot. Industry benchmarks sit between 3% and 15% depending on sector — patent-heavy hardware averages higher than software.
Minimum annual payments. A floor on annual royalties keeps the licensee honest even in slow years and makes the deal produce predictable revenue.
Audit rights. You need contractual access to the licensee's books. No audit clause means no enforcement. No enforcement means no real licence.
Field-of-use restrictions. License the patent for a specific application, not every possible use. This lets you license the same patent to multiple non-competing parties and multiply revenue.
What does the sale-vs-license math actually look like?
Consider a real comparison. A founder has a patent that a buyer has offered to purchase for $2M. Alternatively, a licensee is willing to sign a 10-year licence at 5% of revenue with a $200K upfront fee and a $100K annual minimum. The licensee projects $8M in annual revenue using the technology.
Sale outcome: $2M, taxed as capital gains, done.
License outcome: $200K upfront + ($8M × 5%) × 10 years = $200K + $4M = $4.2M minimum — plus the right to license the same patent to other non-competing fields of use.
The licence is worth 2.1x the sale in direct cashflow before secondary licences. Once you layer in parallel field-of-use licences, total licensing revenue reaches 3x to 5x the sale price on the same asset.
How does Beyond Elevation structure these deals?
Beyond Elevation runs a three-step process on every patent monetisation engagement. First, we audit the portfolio to identify which patents have genuine licensing potential versus which are better sold or abandoned. Not every patent deserves a licence.
Second, we build the financial model for each path — sale, licence, hybrid, patent-backed loan — so the founder sees the real delta in dollars, not theory.
Third, we structure the deal with the required protections: upfront fees, minimum royalties, audit rights, and field-of-use restrictions. The goal is always the same — maximum cashflow, preserved optionality, real enforcement.
This is the framework we used to restructure Position Imaging's 66 patents and to help DGS build a data monetisation structure that anchored a $5B valuation. Companies with patents are 10.2x more likely to secure early-stage funding — because structured IP is a provable asset, not a hope.
What should you do right now?
Stop negotiating the sale. Book an audit first.
If you are weeks away from signing a patent sale, you owe yourself one 30-minute conversation before the ink dries. A licensing structure you never considered is often worth more than the entire sale offer on the table.
Book an IP monetisation audit with Beyond Elevation at beyondelevation.com and we will build the sale-vs-licence model for your specific portfolio before you give the asset away.
FAQ
Is it always better to license patents than sell them?
No. License by default, but sell when the IP is non-core, enforcement is impossible, or cash pressure is terminal. Everything outside those cases favours licensing by a factor of 3x to 10x in total revenue over the patent life.
How long does it take to structure a patent license?
A well-structured patent licence takes 4 to 12 months from first contact to signed agreement. Complex multi-field licences and cross-border deals can take longer. The upfront payment should begin flowing within 30 days of signature.
What royalty rate should I charge on a patent license?
Royalty rates range from 3% to 15% of licensee revenue depending on sector. Hardware and pharma average higher, software lower. Most founders underprice by 50% to 75% because they anchor to what the licensee offers first. Benchmark against comparable arms-length deals before you negotiate.
Can I license the same patent to multiple companies?
Yes, if you write field-of-use restrictions into every licence. A field-of-use clause limits the licensee to a specific application or industry, leaving the patent free to license to non-competing parties in other fields. Done right, this can triple total licensing revenue.
What happens if the licensee stops paying royalties?
Enforcement requires the audit rights and minimum-royalty clauses built into the deal. Without them, you have no recourse. With them, you have a contractual basis to audit, demand payment, and terminate the licence if needed. Beyond Elevation never signs a licence without both protections in place.